amendment:
  amendment_details: '<p>Amendment Details</p>

    <p>This protocol has been amended previously. Details of prior amendments are
    presented in Prior Protocol Amendment(s).</p>

    <p>Current Amendment</p>'
  robustness_impact: false
  robustness_impact_reason: ''
  safety_impact: false
  safety_impact_reason: ''
miscellaneous:
  medical_expert_contact: ''
  sae_reporting_method: ''
  sponsor_signatory: ''
title_page:
  amendment_details: ''
  amendment_identifier: '3'
  amendment_scope: Global
  compound_codes: L04AA56
  compound_names: 'Deucravacitinib

    SOTYKTU'
  manufacturer_name_and_address: ''
  medical_expert_contact: ''
  original_protocol: 'No'
  regulatory_agency_identifiers: 'EU CT 2022-502991-21-00

    '
  sae_reporting_method: ''
  sponsor_approval_date: '2023-11-07T00:00:00'
  sponsor_confidentiality: ''
  sponsor_name_and_address: "Rheinische Friedrich-Wilhelms-Universit\xE4t Bonn\nrepresented\
    \ by the Faculty of Medicine of the University of Bonn represented by the Dean\
    \ of the Faculty of Medicine Venusberg-Campus 1, D-53127 Bonn\nProf. Dr. med.\
    \ Joerg Wenzel Department of Dermatology and Allergology University Hospital of\
    \ Bonn Venusberg- Campus 1, D-53127 Bonn"
  sponsor_signatory: ''
